NCT04206592

Brief Summary

Prospective, controlled, randomized study to compare Ambu AuraGain with Intersurgical i-Gel mask during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The investigators hypothesise that when comparing the Ambu® AuraGainTM with Intersurgical i-GelTM mask, the Ambu® AuraGainTM would exhibit a higher oropharyngeal leak pressure (OLP) during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The main goal is to compare the Ambu AuraGain with the i-Gel in terms of safety and efficacy during mechanical ventilation in critical phase of the pneumoperitoneum in lateral decubitus and reverse trendelemburg position. Secondary objectives are comparing insertion time, number of attempts, ventilatory airway peak pressure, time and success rates for gastric tube insertion and the incidence of side effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 18, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 18, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 17, 2020

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2020

Completed
Last Updated

February 16, 2021

Status Verified

November 1, 2019

Enrollment Period

3 months

First QC Date

December 18, 2019

Last Update Submit

February 14, 2021

Conditions

Keywords

Laryngeal maskOropharyngeal leak pressureLaparoscopic Cholecystectomy

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal leak pressure pneumoperitoneum.

    Oropharyngeal Leak Pressure (OLP) will be measured by closing the expiratory valve of the circle system at a fixed gas flow of 3 litres/min (maximum allowed 40 cmH2O) recording the pressure at which equilibrium has been reached or audible air is leaking.

    10 month

Study Arms (2)

i Gel LMA

ACTIVE COMPARATOR

The sealing pressure of the igel laryngeal mask will be measured during pneumoperitoneum in elective laparoscopic cholecystectomy

Device: Oropharyngeal leak pressure during pneumoperitoneum.

Ambu Aura Gain

ACTIVE COMPARATOR

It will be compared the Ambu Aura Gain LMA vs iGel in elective laparoscopic cholecystectomy

Device: Oropharyngeal leak pressure during pneumoperitoneum.

Interventions

Oropharyngeal Leak Pressure (OLP) will be measured by closing the expiratory valve of the circle system at a fixed gas flow of 3 litres/min (maximum allowed 40 cmH2O) recording the pressure at which equilibrium has been reached or audible air is leaking.

Ambu Aura Gaini Gel LMA

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-80 year
  • American Society of Anaesthesiologists physical status I-III
  • Elective Laparoscopic Cholecystectomy

You may not qualify if:

  • Previous knowledge of difficult intubation
  • Mouth opening less than 35 mm
  • Cervical spine disease
  • BMI≥35 kg/m2
  • Upper respiratory or digestive tract disease
  • Severe obstructive pulmonary disease
  • Recent history of upper respiratory tract infection
  • Pregnancy
  • Patients who have a risk of gastric aspiration
  • Preoperative sore throat
  • Patients who refuse to participate
  • Withdrawal criterion:
  • Orotracheal intubation during surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anesthesia Department, Hospital Plató

Barcelona, 08006, Spain

Location

Study Officials

  • Teresa García-Navia

    Hospital Plato

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2019

First Posted

December 20, 2019

Study Start

November 18, 2019

Primary Completion

February 17, 2020

Study Completion

March 9, 2020

Last Updated

February 16, 2021

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

All IPD that underlie results in a publication

Locations